Status:

UNKNOWN

Remote Ischemic Conditioning for the Treatment of Stroke-related Insomnia

Lead Sponsor:

Ji Xunming,MD,PhD

Conditions:

Acute Ischemic Stroke

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

This study intends to further reveal the effect of RIC in stroke-related insomnia and explore its potential mechanisms.

Detailed Description

Sleep disturbance after stroke is an important factor affecting the prognosis of stroke function. At present, most studies have focused on the diagnosis and treatment of sleep disordered breathing aft...

Eligibility Criteria

Inclusion

  • Aged 18 to 70 years old;
  • mRS≤3;
  • Meeting the DSM-IV diagnostic criteria for insomnia: in the past one month, the presence of any of the following symptoms: a. have difficulty falling asleep (sleep latency \>30 minutes); b. have trouble in maintaining sleep; c. early awakening, accompanied by impaired daytime function, with symptoms occurring more than three times a week, lasting at least 2 weeks;
  • Written informed consent provided by the patients or their legal relatives.

Exclusion

  • Chronic insomnia (PSQI≥8) or other sleep disorders was diagnosed 3 months before onset of stroke;
  • Presence or past history of neuropsychiatric diseases such as epilepsy, brain tumors, neurodegenerative disorders, restless leg syndrome, periodic leg movement;
  • Schizophrenia, significant anxiety and depression (HAMA≥14 points, HAMD≥17 points) with moderate to high suicide risk, etc;
  • Serious infection, malignancy, and other serious medical conditions (acute heart, liver, renal failure and other diseases);
  • Have taken any medications (antipsychotics, hypnotics, antidepressants, etc.) that interfere with sleep in the latest two weeks;
  • Have work shift or jet lag experience 4 months before enrollment Infants, Pregnant or lactating women.

Key Trial Info

Start Date :

April 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 13 2023

Estimated Enrollment :

136 Patients enrolled

Trial Details

Trial ID

NCT05289518

Start Date

April 1 2022

End Date

December 13 2023

Last Update

March 21 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Xuan Wu Hospital,Capital Medical University

Beijing, Beijing Municipality, China, 100053